Cash & equivalents increased 269.0%
Cash & equivalents changed +269.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +269.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed -54.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +55.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed -24.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +60.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -19.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +8.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Debt changed -1.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.